Amello Jason
SEC CIK 1451805 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | CFO | 202.0K | $10.0K | — | 4 | 2022-11-28 | 2023-11-28 |
Most active insiders at CADL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Tak Paul Peter | CEO, Dir | — | $3.16M |
| 2 | Manning Paul B | Dir | $3.00M | — |
| 3 | Barone Francesca | CSO | — | $235.8K |
| 4 | Tyagarajan Seshu | CTO | — | $154.2K |
Amello Jason made no open-market trades at CADL in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-30 | 2023-11-28 | CADL | Candel Therapeutics, Inc. | Amello Jason | CFO | F - Tax | $0.9 | -20.2K | 202.0K | -9% | -$18.1K | |
| 2023-11-28 | 2023-11-26 | CADL | Candel Therapeutics, Inc. | Amello Jason | CFO | A - Grant | $0.00 | +125.7K | 222.2K | +130% | $0 | |
| M | 2022-12-12 | 2022-12-08+ | CADL | Candel Therapeutics, Inc. | Amello Jason | CFO | P - Purchase | $1.80 | +5,568 | 3,100 | New | +$10.0K |
| 2022-11-30 | 2022-11-28 | CADL | Candel Therapeutics, Inc. | Amello Jason | CFO | A - Grant | $0.00 | +90.9K | 90.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations